Zenoss Inc., a leader in intelligent application and service monitoring, announced today that Ani Gujrathi has joined Zenoss as chief technology officer.
Read MorePfizer Inc. (NYSE: PFE) and Array BioPharma Inc. (NASDAQ: ARRY) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array.
Read MoreArcherDX, Inc., today announced the appointment of Steven J. Kafka, Ph.D. as executive chairman of the ArcherDX board of directors.
Read MoreArcherDX, Inc. today announced the closing of an up to $60 million Series B financing round led by Perceptive Advisors. The investor syndicate also includes existing investors PBM Capital, Boulder Ventures, Longwood Fund and Peierls Foundation.
Read MoremiRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced incremental new data from its Phase 1 clinical trial evaluating the safety, tolerability and efficacy of cobomarsen, an inhibitor of microRNA-155, in adult T-cell leukemia/lymphoma (ATLL) in an oral presentation at the 19th International Congress HTLV 2019, which is being held from April 24 – 26, 2019, in Lima, Peru.
Read MoreORIX Growth Capital completes investment in Zenoss, one of the leading technology companies providing modern monitoring and AI-driven analytics for hybrid and multi-cloud IT environments.
Read MoremiRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, today reported financial and operating results for the fourth quarter and full-year ended December 31, 2018.
Read MoreCorporate investments in renewable energy used to be symbolic. A few solar panels here, a small wind farm investment there. But in 2018 some companies became voracious green energy consumers.
Read More